Anticholinergic Activity of Commonly Prescribed Medications and Neuropsychiatric Adverse Events in Older People

Cholinergic Deficiency Hypothesis in Delirium: A Synthesis of Current Evidence

(2011) T. T. Hshieh et al.   JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES

Altered blood-brain-barrier function in Alzheimer's disease?

(2010) K. M. Mattila et al.   ACTA NEUROLOGICA SCANDINAVICA

Two Commonly Used Methods for Exposure-Adverse Events Analysis: Comparisons and Evaluations

(2009) John Z. Duan   JOURNAL OF CLINICAL PHARMACOLOGY

Blood–brain barrier permeability in Alzheimer's disease: a case–control MRI study

(2009) John M. Starr et al.   PSYCHIATRY RESEARCH-NEUROIMAGING

Assessment of Neuropsychiatric Adverse Events in Influenza Patients Treated with Oseltamivir

(2008) Stephen Toovey et al.   DRUG SAFETY

Was the thrombotic risk of rofecoxib predictible from the French Pharmacovigilance Database before 30 September 2004?

(2008) A. Sommet et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Anticholinergic Activity of 107 Medications Commonly Used by Older Adults

(2008) Marci L. Chew et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Blood–brain barrier: Ageing and microvascular disease – systematic review and meta-analysis

(2007) Andrew J. Farrall et al.   NEUROBIOLOGY OF AGING